Statera Biopharma (STAB) Stock Chart & Stock Price History $0.0002 +0.00 (+100.00%) As of 12:50 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock Statera Biopharma Stock Price Performance The Statera Biopharma (STAB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 66.67%, with a year-to-date return of 100.00%. In the past month, the stock has increased 100.00%, reflecting recent market activity. As of the latest close, Statera Biopharma traded at $0.00 with a market cap of $11 thousand and volume of 1,052 shares. Receive STAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Statera Biopharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance0.00%1 Month Performance+100.00%3 Month Performance+100.00%Year-To-Date Performance+100.00%1 Year Performance-66.67% STAB Stock Chart for Thursday, August, 28, 2025 STAB Chart by TradingView Statera Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/27/2025$0.00$0.00$0.00$0.001,052 shs$11,000.0008/26/2025$0.00$0.00$0.00$0.0056,900 shs$11,000.0008/25/2025$0.00$0.00$0.00$0.00279 shs$11,000.0008/22/2025$0.00$0.00$0.00$0.00177 shs$11,000.0008/21/2025$0.00$0.00+100.00%$0.00$0.0018,435 shs$11,000.0008/20/2025$0.00$0.00$0.00$0.001,100 shs$5,000.0008/19/2025$0.00$0.00$0.00$0.001,100 shs$5,000.0008/18/2025$0.00$0.00$0.00$0.00171,268 shs$5,000.0008/15/2025$0.00$0.00$0.00$0.00200 shs$5,000.0008/14/2025$0.00$0.00$0.00$0.001,001 shs$5,000.00 Get the Latest News and Ratings for STAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Statera Biopharma and its competitors with MarketBeat's FREE daily newsletter. 08/13/2025$0.00$0.00$0.00$0.003,350 shs$5,000.0008/12/2025$0.00$0.00$0.00$0.003,350 shs$5,000.0008/11/2025$0.00$0.00$0.00$0.003,350 shs$5,000.0008/08/2025$0.00$0.00$0.00$0.003,350 shs$5,000.0008/07/2025$0.00$0.00$0.00$0.0013,839 shs$5,000.0008/06/2025$0.00$0.00$0.00$0.001,939 shs$5,000.0008/05/2025N/A$0.00$0.00$0.00125 shs$5,000.0008/01/2025$0.00$0.00$0.00$0.001,360 shs$5,000.0007/31/2025$0.00$0.00$0.00$0.001,360 shs$5,000.0007/30/2025$0.00$0.00$0.00$0.001,360 shs$5,000.0007/29/2025$0.00$0.00$0.00$0.00575 shs$5,000.0007/28/2025$0.00$0.00$0.00$0.00100 shs$5,000.00 Related Companies Syros Pharmaceuticals Stock Chart Virpax Pharmaceuticals Stock Chart Scopus BioPharma Stock Chart Evelo Biosciences Stock Chart Comera Life Sciences Stock Chart Genocea Biosciences Stock Chart Genocea Biosciences Stock Chart Aridis Pharmaceuticals Stock Chart Ampio Pharmaceuticals Stock Chart PaxMedica Stock Chart Receive STAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Statera Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:STAB) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Statera Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Statera Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access